Marico just closed the books on a ₹1,012.03 crore deal to buy another 24.09% chunk of Satiya Nutraceuticals, the parent of health brand PLIX. Per the BSE filing dated October 5, this move pushes Marico’s total stake in the wellness player to 84.09% on a fully diluted basis. It’s a significant consolidation play.
The numbers add up. For the 84.09% stake, Marico’s aggregate consideration stands at ₹1,392.07 crore. The remaining 14.09% is slated for a July 2027 pickup, with a base price capped at ₹592 crore plus milestone-linked payments. Marico had earlier grabbed 60% and exercised its option to buy more from founders and other shareholders. No regulatory hurdles delayed the deal; it cleared on arm’s-length terms.
Why the push? Marico says this expands its addressable market in value-added foods and nutrition while beefing up its personal care footprint. Satiya Nutraceuticals also owns Juizo Advisory, a wholly owned subsidiary. The strategic bet is clear: consolidate the wellness space before competitors circle.
On the earnings front, Marico signaled strong Q2 momentum. The company expects to beat near-term guidance across key parameters. India business volumes hit double-digit growth. Parachute Coconut Oil saw early-teens volume growth, while Saffola Oil posted mid-single-digit price-led gains despite lower volumes as Marico prioritized profitability over scale for select variants.
Watch the July 2027 deadline. That’s when the final 14.09% stake is expected to transfer, subject to agreement terms. For now, Marico’s balance sheet absorbs the ₹1,392 crore outlay, positioning it as a dominant player in the health and wellness segment.